Program 762,
  December 3, 2002

 

A. One Step Beyond 'Smart Bomb Therapy'

Narrator: This is Science Today. For roughly a century, one of the goals in medicine had been to use radioactivity to target and irradiate tumors. It's only been recently that the FDA approved a cancer therapy that uses this technique, which is called smart bomb therapy. Claude Meares, a professor of chemistry at the University of California, Davis explains how it works.

Meares: If you want to deliver radiotherapy to a cancer and not to normal a very nice way to do that is to use an antibody, load that antibody up with something that will deliver radiation and allow it to float through the body until it finds a cancer cell and stick there and irradiate the cell.

Narrator: Meares is working on a technique that goes a step beyond this concept.

Meares: What we do is use antibodies, but we don't load them up with radiation. We load them up with a receptor molecule that is not radioactive and doesn't irradiate any normal tissue.

Narrator: For Science Today, I'm Larissa Branin.

B. Measuring Social Status and Disease

Narrator: This is Science Today. Physical and emotional health are known to be affected by social relationships, but a University of California, San Francisco psychologist has found that more specifically, there's an important link between one's perceived social status and their health. Nancy Adler helped develop a tool designed to measure how people perceive their social status.

Adler: What we've created was literally a social ladder. We showed people a ladder with ten rungs and said - imagine everyone in US society is somewhere on this ladder, that people at the top are the best off. They have the most income, the best jobs, most education. People at the bottom are the worst off - where would you place yourself?

Narrator: Where people placed themselves correlated to a number of physical and mental health indicators, including susceptibility to the common cold. Adler also used this scale to link adolescents' perception of their social status to obesity and depression.

Adler: So the question of how early on this gets socialized and how you can help kids develop a better sense of themselves.

Narrator: For Science Today, I'm Larissa Branin.

C. How Good is Your Sense of Smell?

Narrator: This is Science Today. How good is your sense of smell? Chances are -you may not be the best judge. Noam Sobel, a neuroscientist at the University of California, Berkeley, conducts olfactory studies and says people often have a poor appreciation of their own sense of smell.

Sobel: We'll have people walk into lab and say 'oh, I'm like a rat, I can sniff out anything' and we'll test them and they'll actually be in terms of threshold, average. And in turn we'll have people come into the lab and say, 'oh, I can't smell a thing'. We'll test them and they'll be keen as a bat.

Narrator: Sobel says the reason for these olfactory discrepancies ties in to how people actually use the information coming from their nose to their brain.

Sobel: It's almost saying like the differences between people in this respect are largely attentional-or to some extent attentional. There are people who pay a lot of attention to olfaction.

Narrator: Sobel recently conducted a study that found that the ability to learn a new smell not only occurs in the nose, but also in the brain. For Science Today, I'm Larissa Branin.

D. The Risks Involved with Smallpox Vaccination

Narrator: This is Science Today. With global concerns about a smallpox pandemic on the rise, experts researching smallpox prevention are looking to the past to improve options for the future. Epidemiologist Arthur Reingold of the School of Public Health at the University of California, Berkeley describes the risks involved with smallpox vaccination.

Reingold: The real complexity about vaccinating large numbers of people against smallpox is that at least the old vaccine we know caused substantial side effects in people and not only at a predictable rate of mortality, but substantial morbidity, that is to say illness, some of which is quite serious.

Narrator: Reingold says that people can recover from many of the side effects but the need for better vaccines and viral treatments associated with smallpox is crucial.

Reingold: The old vaccine was made under conditions that today would be considered extremely primitive. There already is work underway to produce a much more modern smallpox vaccine, and ultimately to produce enough doses for the whole country.

Narrator: For Science Today, I'm Larissa Branin.

E. Timing is Everything When a Heart Attack Strikes

Narrator: This is Science Today. Previous studies have shown that when symptoms of a heart attack strike, people delay seeking treatment. But the longer one delays, the more damage to the heart muscle. Kathleen Dracup of the University of California, San Francisco's School of Nursing, says unfortunately only twenty-five percent of heart attack patients receive treatment within the first two hours.

Dracup: So the challenge for us as health professionals is trying to help people be sensitive to their cardiac symptoms and know what to do right away so that they don't delay - they don't spend their time doing other things - self treatment, taking Maalox, trying to call their doctor, which is not the right thing to do.

Narrator: Dracup says it's equally important that families understand what to do as well.

Hinshaw: What we found they hope, like the patient, that this isn't anything. And yet, the reality is - if it is a heart attack, the best thing to do would be to come immediately.

Narrator: For Science Today, I'm Larissa Branin.

 

 

Science Today is produced by the University of California
  Office of the President
and broadcast over the CBS Radio Network

For comments or more information about Science Today, contact Larissa Branin at larissa.branin@ucop.edu